Identical to test product except without active substance
Sponsors
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret A.S., Astrocyte Pharmaceuticals Inc.
Conditions
Parkinson’s DiseaseTraumatic brain injury
Phase 2
A Phase 2, Randomized, Double-blind, Placebo-Controlled, Single-Center Study to Assess the effects of SUL-238 on High Energy Phosphates with Magnetic Resonance Spectroscopy (31P-MRS) in patients with Early, untreated Parkinson’s Disease (“SHEPHERD” STUDY)
Not yet recruitingCTIS2025-524674-42-00
Target: 45Updated: 2026-02-13
Cosmos Trial: Cerebroprotection Of AST-004 in Mild Complicated Traumatic Brain Injuries
Not yet recruitingCTIS2026-525554-11-00
Target: 48Updated: 2026-06-04